Calcium
Adequate calcium intake supports bone mineralization while raloxifene reduces bone resorption.
Recommendation: Use diet first when possible; supplement only enough to meet recommended intake and avoid excessive calcium.
Prescription ·Strong evidence ·Reviewed May 2026
Raloxifene is a selective estrogen receptor modulator used in postmenopausal women for osteoporosis treatment or prevention and for reduction of invasive breast cancer risk in selected high-risk groups. It improves spine bone density and lowers vertebral fracture risk but increases venous thromboembolism risk and carries a boxed warning for increased risk of venous thromboembolism and death from stroke in women with coronary heart disease or high coronary risk.
The bottom line
Evidence rating strong. Most-documented uses: treatment of postmenopausal osteoporosis, prevention of postmenopausal osteoporosis, reduced vertebral fracture risk. 3 sources indexed (1999–2026), with 4 interaction records on file.
Core mechanism
Raloxifene acts as an estrogen receptor agonist in bone and lipid metabolism while acting as an antagonist in breast and uterine tissue. In bone, it decreases osteoclast-mediated resorption and turnover, preserving bone mineral density. Its hepatic and coagulation effects contribute to reduced LDL cholesterol but also increased venous thromboembolism risk.2,1
May be taken with or without food. Avoid use during prolonged immobilization and follow label guidance around surgery or immobilization because of clot risk.
Adequate calcium intake supports bone mineralization while raloxifene reduces bone resorption.
Recommendation: Use diet first when possible; supplement only enough to meet recommended intake and avoid excessive calcium.
Vitamin D sufficiency improves calcium absorption and supports raloxifene-based osteoporosis care.
Recommendation: Correct deficiency and maintain adequate intake; monitor levels when deficiency risk is high.
Vitamin K2 is sometimes used for bone matrix protein carboxylation and may overlap with bone-health goals.
Recommendation: Use as adjunctive nutrition support only; it does not offset raloxifene clot or stroke risk.
Large doses of soluble fiber can reduce or delay absorption of some oral drugs and may make raloxifene exposure less predictable.
Recommendation: Separate psyllium from raloxifene by at least 2 hours if both are used daily.
Numbered references. Citations throughout the page link here.
RUTH trial clarified benefit and vascular risk tradeoffs in women with coronary disease or risk factors.
MORE trial data support vertebral fracture reduction and bone density effects.
Labeling describes 60 mg daily dosing, osteoporosis and breast cancer risk indications, VTE contraindication, and boxed warning.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.